Results 1 to 10 of about 22,656 (208)

International antiemetic guidelines on chemotherapy induced nausea and vomiting (CINV) : content and implementation in daily routine practice

open access: yesEuropean Journal of Pharmacology, 2014
Over the past decades major improvements in the management of chemotherapy induced nausea and vomiting (CINV) were obtained. With the correct use of antiemetic drugs, CINV can be prevented in almost 70%, and even up to, 80% of patients.
Gralla, R   +7 more
core   +2 more sources

A Scoping Review of 5-HT<sub>3</sub> Antagonist Antiemetic Medication Safety in the Management of Nausea and Vomiting of Pregnancy. [PDF]

open access: yesPharmacoepidemiol Drug Saf
ABSTRACT Purpose The prescribing of 5‐hydroxytryptamine 3 receptor and type 3 serotonin receptor (5‐HT3) antagonists, particularly ondansetron, for nausea and vomiting in pregnancy (NVP) has increased globally. However, evidence on the safety of these medications in pregnancy remains unclear.
Morgan S   +6 more
europepmc   +2 more sources

Receptor-Targeted Antiemetic Strategies in Cats: A Systematic Review and Intervention-Specific Meta-Analysis. [PDF]

open access: yesVet Med Sci
Maropitant showed the most consistent controlled evidence for reducing emesis incidence in cats under perioperative or induced‐emesis conditions. Ondansetron may be beneficial in timing‐specific settings, whereas metoclopramide evidence remains insufficient for pooled inference. .
Ersöz U, Özkalipci Ç.
europepmc   +2 more sources

What changes in prescription patterns of antiemetic medications in pregnant women in France?

open access: yesFundamental and Clinical Pharmacology, 2021
International audienceBackground In France, few data are available on the prescription patterns of antiemetic medications in pregnant women. Objectives The purpose of this study was to describe antiemetic medication prescriptions and trends over time ...
Isabelle Lacroix   +11 more
core   +2 more sources

Chemotherapy-Induced Nausea and Vomiting in Early Breast Cancer Patients Receiving Adjuvant Chemotherapy With Fluorouracil, Epirubicin, Cyclophosphamide Followed by Docetaxel Versus an Anthracycline-Free Regimen With Docetaxel, Cyclophosphamide-Results From a Randomized Clinical Trial. [PDF]

open access: yesInt J Cancer
Chemotherapy‐induced nausea and vomiting (CINV) remains a significant clinical problem despite modern antiemetics. In particular, antiemetic strategies for emerging cancer therapies lack detailed evaluation. This randomized trial analyzed hourly CINV data for patients with early breast cancer who received either docetaxel plus cyclophosphamide (TC) or ...
Hörner M   +16 more
europepmc   +2 more sources

Pharmaceutical policy and off-label prescribing in pregnancy: A population-based historical cohort study analyzing inequality in access to antiemetics within Australia's Pharmaceutical Benefits Scheme. [PDF]

open access: yesActa Obstet Gynecol Scand
Public spending on antiemetics among pregnant women in Australia is concentrated in socioeconomically disadvantaged women. However, public expenditure is also driven by off‐label ondansetron use (i.e., use outside regulatory‐approved indications), highlighting a misalignment between pharmaceutical policy, public expenditure patterns, and pregnant women'
Jackson H   +4 more
europepmc   +2 more sources

Analysis of Antiemetic Use After Initiation of Hormone Therapy [PDF]

open access: yes, 2022
This cross-sectional study investigates the occurrence of the prescribing cascade of antiemetic after hormone ...
Lund, Lars Christian; id_orcid   +6 more
core   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

Antiemetic Strategies in Patients Who Undergo Hematopoietic Stem Cell Transplantation

open access: yes, 2022
Hematopoietic stem cell transplantation (HSCT) is an integral part of the treatment strategy in patients with a hematological disorder. Chemotherapy-induced nausea and vomiting (CINV) is still an issue in patients who undergo HSCT.
Gatwood, Katie S.   +7 more
core   +1 more source

Antiemetic therapy in Asia Pacific countries for patients receiving moderately and highly emetogenic chemotherapy-a descriptive analysis of practice patterns, antiemetic quality of care, and use of antiemetic guidelines

open access: yes, 2017
This paper reports prescribing patterns for prophylaxis of chemotherapy-induced nausea and vomiting (CINV) after highly or moderately emetogenic chemotherapy (HEC or MEC) for cancer in six Asia Pacific countries. ;In a prospective noninterventional study,
Yu, Shiying;Burke, Thomas A.;Chan, Alexandre;Kim, Hoon-Kyo;Hsieh, Ruey Kuen;Hu, Xichun;Liang, Jin-Tung;Banos, Ana;Spiteri, Carmel;Keefe, Dorothy M. K.   +1 more
core   +1 more source

Home - About - Disclaimer - Privacy